Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fasinumab for Pain in Chronic Pancreatitis
NCT01001923Phase 2Terminated
- Sponsor
- Regeneron Pharmaceuticals
- Start
- Dec 2009
- Primary completion
- Jan 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of fasinumab in chronic pancreatitis (CP), sponsored by Regeneron Pharmaceuticals. Started Dec 2009; status: terminated.
02
Drugs
fasinumab
03
Conditions
chronic pancreatitis (CP)
Beyond the preview
Go deeper on NCT01001923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01001923.